Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5658 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 24 25 26 ... 55 56 57  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Symphogen–Selexis: cell line development, 201412– license to SUREtechnology platform + SURE CHO-M Cell Line + collab RnD 2014-12-09
BioCat GmbH–Genetrix (ES): TruePrime, 201412– distribution non-excl of Sygnis’ TruePrime Single Cell WGA kit by BioCat 2014-12-08
KWS Saat–Metabolomic Discoveries: metabolomic services, 201412– supply service 3y to study + improve KWS crops on biochemical level 2014-12-05
Sigma-Aldrich–MIT: CRISPR technology, 201412– non-excl license to foundational CRISPR patents from Broad Institute 2014-12-04
Anergis–SEVERAL: investment, 201412 financing round Series B CHF14.5m (€12.1m) co-led by Sunstone Capital + BioMedInvest + Renaissance PME + WJFS 2014-12-03
Ariosa Diagnostics–Roche: investment, 201412 acquisition by Roche 2014-12-02
Ayoxxa–SEVERAL: investment, 201412 financing round Series B extension €2.3m from BioMedPartners AG + Grazia Equity GmbH 2014-12-02
Bayer–Orion Corp: cancer drug, 201412 existent collab ww developm + marketing of oral androgen receptor modulator ODM-201 for prostate cancer 2014-12-02
BioVersys–Enamine: drug discovery services, 201412– collab extension €na supply services for discovery of new antibiotics 2014-12-02
Xeltis–Kurma: investment, 201412 financing round Series B totalling €27m co-led by LSP + Kurma Partners 2014-12-02
Xeltis–Life Sciences Partners: investment, 201412 financing round Series B totalling €27m co-led by LSP + Kurma Partners 2014-12-02
Xeltis–SEVERAL: investment, 201412 financing round Series B €27m co-led by LSP + Kurma Partners plus VI Partners + current investors 2014-12-02
Xeltis–VI Partners: investment, 201412 financing round Series B totalling €27m incl co-investor VI Partners 2014-12-02
InnoLife project–EU (govt): grant, 201412– KIC grant of up to €700m out of a total project volume >€2b 2014-12-01
Nanolive–SEVERAL: investment, 201412 closing of 1st financing round 2014-12-01
Pieris–MacDougall Biomedical Communications: public relations, 201412 service existent 2014-12-01
Sartorius–SEVERAL: credit, 201412– syndicated €400m 5-year loan from bank syndicate led by BNP Paribas + Commerzbank + LBBW 2014-12-01
Tiziana–Novimmune: therapeutic antibody, 201412– license to foralumab (NI-0401) to Tiziana 2014-12-01
Uniqure–MacDougall Biomedical Communications: public relations, 201412 service existent 2014-12-01
Boehringer–NanoPET Pharma: contrast medium, 201411– collab development of contrast media for use in preclinical research 2014-11-30
WeissBioTech–BRAIN: investment, 201411 acquisition €na of majority shareholding in WeissBioTech GmbH by BRAIN AG 2014-11-27
Promethera–SEVERAL: investment, 201411 financing round Series C €20.33m incl new investors SFPI-FPIM + SMS Investments 2014-11-25
Promethera–Wallonia (govt): credit, 201411 loans + subisidies totalling €5m to support clinical development of HepaStem + collab w EMD-Millipore 2014-11-25
PS Biotech–SEVERAL: investment, 201411 financing round Series A 2014-11-25
Curetis–Life Sciences Partners: investment, 201411 financing round Series B extension totalling €14.5m incl €7m from new investors LSP-HEF + Qiagen 2014-11-24
Curetis–Qiagen: investment, 201411 financing round Series B extension totalling €14.5m incl €7m from two new investors Qiagen + LSP-HEF 2014-11-24
Curetis–SEVERAL: investment, 201411 financing round Series B extension €14.5m new investors Qiagen + LSP-HEF + all existing investors 2014-11-24
AstraZeneca–Biognosys: mass spectrometry services, 201411– supply Proteome-SEQ service to AstraZeneca 2014-11-21
BioNano Genomics–Novartis: investment, 201411 financing round Series C totalling $53m co-led by new investor Novartis Venture Fund 2014-11-20
BioNano Genomics–SEVERAL: investment, 201411 financing round Series C $53m co-led by new investors Legend Capital + Novartis Venture Fund 2014-11-20
MagForce–SEVERAL: investment, 201411 capital increase €10.2m placing 1.7m new shares €6/share 2014-11-20
NEU² project–Metabolomic Discoveries: biomarker discovery, 201411– collab to identify metabolomic markers for MS with Fraunhofer IME + UKE 2014-11-20
Roche–Axxam: drug discovery services, 201411– supply drug screening + assay development services by Axxam + HDC 2014-11-19
Allylix–Evolva: investment, 201411–201412 acquisition merger for 46m new Evolva shares representing 14.1% post-merger share 2014-11-18
Evolva–Cargill: investment, 201411 investment $4m to support merger acquisition of Allylix by Evolva 2014-11-18
Intellia Therapeutics–Atlas Venture: investment, 201411 financing round Series A totalling $15m led by Atlas Venture + Novartis 2014-11-18
Intellia Therapeutics–Novartis: investment, 201411 financing round Series A totalling $15m led by Atlas Venture + Novartis 2014-11-18
Intellia Therapeutics–SEVERAL: investment, 201411 financing round Series A $15m led by Atlas Venture + Novartis 2014-11-18
Pepperprint–Sciomics: microarray technology, 201411– collab distribution + marketing for antibody characterisation + biomarker discovery 2014-11-18
Pfizer–Merck (DE): antibody cancer drug, 201411– collab dev + commerc of anti-PD-L1 antibody $850m upfront + $2b milestones + shared costs + revenues 2014-11-17
Protagen–BioStrata: public relations, 201411 service existent by BioStrata 2014-11-17
Qiagen–Protagen: proteomic companion diagnostics, 201410– collab €na developm for autoimmune therapies using SeroTag platform 2014-11-17
Bruker Corp–Premier Biosoft: mass spectrometry s/w, 201411– distribution co-marketing + resale of SimLipid s/w + SimMet s/w by Bruker 2014-11-14
Cogent Healthcare–Fresenius: investment, 201411– acquisition €na of Cogent by Sound Physicians Inc ANNOUNCED 2014-11-13
Univ Furtwangen–Danaher: mass spectrometer, 201411 supply existent AB Sciex QTRAP 4000 system used by Prof Fath for water analysis 2014-11-13
Novartis–Qiagen: molecular companion diagnostics, 201411– collab €na master agreement devlepm + commercialisation of CDx for Novartis drugs 2014-11-11
Histide–SEVERAL: investment, 201411 financing round Series A CHF4.5m ($4.6m) led by Parter Capital + private investors 2014-11-10
Humedics–SEVERAL: investment, 201411 financing round Series C €6.3 led by new investors Vesalius Biocapital Partners + Seventure Partners 2014-11-10
Siemens–SEVERAL: investment, 201411 acquisition of Siemens Audiology Solutions for €2.15b plus earn-out by EQT + Strüngmann family 2014-11-06
Definiens–AstraZeneca: investment, 201411 acquisition $150m upfront + milestones by MedImmune 2014-11-04
Bruker Corp–Techcomp: investment, 201411 acquisition of GC + GC-SQ SCION business by Techcomp Europe Ltd 2014-11-03
Dihon Pharmaceutical–Bayer: investment, 201411 acquisition for CNY3.6b=€460m 2014-11-03
Covance–LabCorp: investment, 201411–201502 acquisition $6.2b w $107.19/share paid $75.76 in cash + 0.26886 LabCorp shares per Covance share 2014-11-02
EBOKON project–Germany (govt): grant, 201411–201512 BMBF grant €2.3m to DZIF + partners for Ebola virus research 2014-11-01
Servier–GeNeuro: GNbAC1 MAb, 201411– collab developm + marketing for MS w excl license option ww excl US+JP $47m upfront + $408 milestones + royalties 2014-11-01
MYR GmbH–High-Tech Gründerfonds: investment, 201410 financing round totalling €7.9m from Maxwell Biotech Venture Fund + HTGF 2014-10-31
MYR GmbH–Russia (govt): investment, 201410 financing round totalling €7.9m from Maxwell Biotech Venture Fund + HTGF 2014-10-31
MYR GmbH–SEVERAL: investment, 201410 financing round €7.9m from Maxwell Biotech Venture Fund + HTGF 2014-10-31
Deutsche Messe–Select Biosciences: European Lab Automation conference, 201410–201510 collab co-hosting of ELA 2015 + Labvolution 2015 in Hannover 2014-10-30
Bayer–DuPont: herbicides, 201410–201412 acquisition €na approx 30 herbicides for land management from DuPont Crop Protection by Bayer CropScience 2014-10-29
Eurofins–Igenbio: genomic services, 201410– collab product integration for one-stop-shopping solution by Eurofins Genomics + Igenbio 2014-10-29
Affimed–Distributed Bio: antibody technology, –201410 co-development of AbAccel technology platform with AbCheck 2014-10-28
Astellas–Qiagen: molecular companion diagnostics, 201410– collab €na master agreement devlepm + commercialisation of CDx for Astellas drugs 2014-10-28
Cunesoft–Bavaria (govt): investment, 201410 financing round with HTGF + Bayern Kapital 2014-10-28
Cunesoft–High-Tech Gründerfonds: investment, 201410 financing round with HTGF + Bayern Kapital 2014-10-28
Cunesoft–SEVERAL: investment, 201410 financing round with HTGF + Bayern Kapital 2014-10-28
Imevax–BioMedPartners: investment, 201410 financing round Series A totalling €7.5m incl co-lead investor BioMedInvest-II LP fund 2014-10-28
Imevax–EMBL: investment, 201410 financing round Series A totalling €7.5m incl co-lead investor EMBL Ventures 2014-10-28
Imevax–MC Services: public relations, 201410 service existent by MC Services AG 2014-10-28
Imevax–SEVERAL: investment, 201410 financing round Series A €7.5m led by Wellington Partners 2014-10-28
Imevax–Strüngmann Group: investment, 201410 financing round Series A totalling €7.5m incl co-lead investor Santo Venture Capital 2014-10-28
Imevax–Wellington Partners: investment, 201410 financing round Series A totalling €7.5m incl lead investor Wellington Partners 2014-10-28
National Cardiovascular Partners–Fresenius: investment, 201410 acquisition €na of NCP by Fresenius Medical Care 2014-10-22
YES Pharma Services–Auctus Capital: investment, 201410 acquisition of majority share by funds advised by Auctus Capital Partners AG 2014-10-22
VBC-Biotech–Eurofins: investment, 201410 acquisition merger establishing Eurofins Genomics AT GmbH taking over VBC services 2014-10-21
Weizmann Institute–XL-protein: PASylation technology, 201410– Yeda acquires ww excl marketing + outlicensing rights to PAS-YNSa8 dev by XL + Weizmann 2014-10-21
Univ Lausanne–Thermo Fisher: mass spectrometer, 201410 supply existent Bertrand Rochat early access user of Q Exactive Focus LC-MS/MS system 2014-10-20
Epigenomics–BioChain: investment, 201410 acquisition €4.2m 1.35m new shares €3.08/share by BioChain Institute Inc 2014-10-16
Roche–NewLink Genetics: cancer drugs, 201410– collab drug discovery IDO/TDO inhibitors with Genentech 2014-10-16
MorphoSys–Lanthio Pharma: LanthioPep technology, 201410 acquisition €na technology + all related IP by MorphoSys 2014-10-15
Bicylce Therapeutics–SEVERAL: investment, 201410 financing round £20m incl Atlas Venture + Novartis VF + SR One + SVLS + Astellas Venture 2014-10-14
Raze Therapeutics–SEVERAL: investment, 201410 financing round Series A $24m from Atlas Venture + MPM + MS Ventures + PIF + Astellas + Novartis 2014-10-14
Rigontec–Boehringer: investment, 201410 financing round Series A 1st closing totalling €9.45m co-led by Wellington Partners + BIVF 2014-10-14
Rigontec–High-Tech Gründerfonds: investment, 201410 financing round Series A 1st closing totalling €9.45m incl co-investor HTGF 2014-10-14
Rigontec–Huntsworth: public relations, 201410 service existent by Citigate Dewe Rogerson 2014-10-14
Rigontec–North Rhine-Westphalia (govt): investment, 201410 financing round Series A 1st closing totalling €9.45m incl co-investor NRW.Bank 2014-10-14
Rigontec–SEVERAL: investment, 201410 financing round Series A 1st closing €9.45m co-led by Wellington Partners + BIVF 2014-10-14
Rigontec–Wellington Partners: investment, 201410 financing round Series A 1st closing totalling €9.45m co-led by Wellington Partners + BIVF 2014-10-14
Probiodrug–Hume Brophy: public relations, 201410 service existent by Hume Brophy 2014-10-10
4 Animals AlsterScience–Hamburg (govt): investment, 201410 seed financing round from HTGF + Innovationsstarter Fonds + Business Angel 2014-10-09
4 Animals AlsterScience–High-Tech Gründerfonds: investment, 201410 seed financing round from HTGF + Innovationsstarter Fonds + Business Angel 2014-10-09
4 Animals AlsterScience–SEVERAL: investment, 201410 seed financing round from HTGF + Innovationsstarter Fonds + Business Angel 2014-10-09
Roche–AbVitro: PETE technology, 201410 acquisition €na of primer extension based target enrichment technology by Roche 2014-10-09
Mimetas–SEVERAL: investment, 201510 financing round $5.2m from ZIF + PPM Oost et al 2014-10-08
Horizon Discovery–Haplogen: cell lines, 201410– distribution ww of cell line engineering services + Haplogen human knockout cell lines by Horizon 2014-10-06
TVM–SEVERAL: investment, 201410 final closing of $201.6m fund TVM Life Science Ventures VII incl Teralys Capital + Lilly 2014-10-06
Cell Marque–Sigma-Aldrich: investment, 201410–201411 acquisition €na of Cell Marque Corp by Sigma-Aldrich 2014-10-03
Forbion–SEVERAL: investment, 201410 first close €92m of FCF III fund with target size of €150–200m 2014-10-03
Danaher–Illumina: OneOmics cloud computing environment, 201410– collab product integration Illumina NGS w AB Sciex SWATH proteomics on BaseSpace 2014-10-02
Abionic–SEVERAL: investment, 201410 financing round Series B CHF3.8m 2014-10-01
next pagenext page 1 2 3 ... 24 25 26 ... 55 56 57  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top